Who is sponsoring NCT06042348?

NCT06042348 is sponsored by Maxima Medical Center.

What drugs are being tested in NCT06042348?

Interventions in NCT06042348: Trans abdominal ultrasound.

What condition does NCT06042348 study?

NCT06042348 studies Placenta Diseases, Diagnosis, Pregnancy Related, Female, Human.

Is NCT06042348 still recruiting?

NCT06042348 is currently status unknown. Last updated 18 September 2023.

Last reviewed 2023-09-18 · How we verify

NCT06042348: P2SS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Placenta Perfusion and Sufficiency Study

Status unknown Last updated 18 September 2023

What this trial tests

trial testing Trans abdominal ultrasound in Placenta Diseases, Diagnosis in 10 participants. Status unknown.

Timeline

15 September 2023

Primary endpoint
1 December 2023

31 January 2024

Quick facts

Lead sponsor	Maxima Medical Center
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	10
Start date	15 September 2023
Primary completion	1 December 2023
Estimated completion	31 January 2024
Sites	1 location across Netherlands

Drugs / interventions tested

Trans abdominal ultrasound

Conditions studied

Placenta Diseases, Diagnosis — all drugs for Placenta Diseases, Diagnosis →
Pregnancy Related — all drugs for Pregnancy Related →
Female — all drugs for Female →
Human — all drugs for Human →

Sponsor

Maxima Medical Center

Who can join

Adults 18 to 40, female only, with Placenta Diseases, Diagnosis or Pregnancy Related. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ultrasonography will be used to determine the total blood flow to and from the uterus. This is done by measuring the blood vessels coming from and going to the uterus. This wil hopefully prove viable and open the possibility to further research in the clinical relevance of these measurements.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Maxima Medical Center trials

Trials by the same sponsor.

NCT07422181 — PlaCEUS: Feasibility Study of Contrast-enhanced Ultrasound to Visualize Maternal Uterine Spiral Arteries Postpartum. · NA · recruiting
NCT07077109 — Feasibility Study: Continuous Fetal Monitoring During Maternal Exercise · NA · not yet recruiting
NCT07061366 — The Use of the Bambi-Belt in Exteremly Preterm Infants: an Implementation Study. · recruiting
NCT07152106 — Amniotic Fluid & the Preterm Gut · recruiting
NCT06392178 — SugarVita: a Digital Board Game · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06042348 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Maxima Medical Center
Last refreshed: 18 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06042348.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing